Literature DB >> 15140562

Toosendanin, a triterpenoid derivative, increases Ca2+ current in NG108-15 cells via L-type channels.

Mu-Feng Li1, Ying Wu, Zhong-Feng Wang, Yu-Liang Shi.   

Abstract

Toosendanin, a triterpenoid derivative extracted from Melia toosendan Sieb et Zucc, was demonstrated to be a selective presynaptic blocker and an effective antibotulismic agent in previous studies. Here, we observed its effects on Ca(2+) channels in NG108-15 cells by whole-cell patch-clamp recording. Obtained data showed that toosendanin concentration dependently increased the high-voltage-activated (HVA) Ca(2+) current with an EC(50) of 5.13 microM in differentiated NG108-15 cells. The enhancement effect was still observed when the cells were pretreated with 5 microM omega-conotoxin MVIIC. However, when the cells were preincubated with 5 microM nifedipine or 10 microM verapamil-containing solution, the effect was absent. In undifferentiated NG108-15 cells, which only express T-type Ca(2+) channels, toosendanin did not affect Ca(2+) currents. These results show that toosendanin increases Ca(2+) influx in NG108-15 cells via L-type Ca(2+) channels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15140562     DOI: 10.1016/j.neures.2004.02.012

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  4 in total

1.  Growth inhibition and apoptosis-induced effect on human cancer cells of toosendanin, a triterpenoid derivative from chinese traditional medicine.

Authors:  Bin Zhang; Zhong-Feng Wang; Mian-Zhi Tang; Yu-Liang Shi
Journal:  Invest New Drugs       Date:  2005-12       Impact factor: 3.850

2.  The anti-botulism triterpenoid toosendanin elicits calcium increase and exocytosis in rat sensory neurons.

Authors:  Xiao Feng Fang; Zong Jie Cui
Journal:  Cell Mol Neurobiol       Date:  2011-06-09       Impact factor: 5.046

3.  Identification of novel host-targeted compounds that protect from anthrax lethal toxin-induced cell death.

Authors:  Louise H Slater; Erik C Hett; Kevin Mark; Nicole M Chumbler; Deepa Patel; D Borden Lacy; R John Collier; Deborah T Hung
Journal:  ACS Chem Biol       Date:  2013-02-04       Impact factor: 5.100

4.  Reversal of the Apoptotic Resistance of Non-Small-Cell Lung Carcinoma towards TRAIL by Natural Product Toosendanin.

Authors:  Xin Li; Ming You; Yong-Jian Liu; Lin Ma; Pei-Pei Jin; Ri Zhou; Zhao-Xin Zhang; Baojin Hua; Xiao-Jun Ji; Xiao-Ying Cheng; Fangzhou Yin; Yan Chen; Wu Yin
Journal:  Sci Rep       Date:  2017-02-17       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.